MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galectin Therapeutics (GALT) Earnings Date & Reports
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
GALT is expected to report earnings to fall 64.29% to -5 cents per share on November 13
Q3'26
Est.
$-0.05
Q2'26
Missed
by $0.07
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.07
The last earnings report on August 14 showed earnings per share of -14 cents, missing the estimate of -7 cents. With 186.49K shares outstanding, the current market capitalization sits at 339.86M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
9
Web
https://www.galectintherapeutics.com